According to market projections, the hormonal replacement therapy sector is expected to grow from USD 24.26 billion in 2024 to USD 46.32 billion by 2034, reflecting a CAGR of 6.68%. In 2024, North America led the hormonal replacement therapy market with a 40% share, while Asia Pacific is set for the fastest growth. Estrogen and progesterone therapy dominated by product, with parathyroid therapy growing rapidly. Oral administration was most common and menopause was the top treated condition.
Last Updated : 01 November 2025 Category: Therapeutic Area Insight Code: 5495 Format: PDF / PPT / ExcelDeepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.
Learn more about Deepa PandeyAditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.
Learn more about Aditi ShivarkarBy clicking “Accept All Cookies” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Privacy Policy